Causes of Syncope in Patients with Alzheimer’s Disease Treated with Donepezil

Author： Bordier Philippe   Lanusse Stephane   Garrigue Stephane   Reynard Charlotte   Robert Frederic   Gencel Laurent   Lafitte Alexia  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.22, Iss.8, 2005-01, pp. : 687-694

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiovascular Effects and Risk of Syncope Related to Donepezil in Patients with Alzheimer's Disease

By Bordier Philippe   Garrigue Stephane   Lanusse Stephane   Margaine Julien   Robert Frederic   Gencel Laurent   Lafitte Alexia  

CNS Drugs, Vol. 20, Iss. 5, 2006-01 ,pp. : 411-417

Adis International

Access to resources Recommend Favorite

The pharmacology of donepezil: a new treatment for Alzheimer’s disease

By Wilkinson D.G.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 1, 1999-11 ,pp. : 121-135

Informa Healthcare

Access to resources Recommend Favorite

Risk of Antipsychotic Drug Use in Patients with Alzheimer’s Disease Treated with Rivastigmine

By Suh D-C.  

Drugs & Aging, Vol. 21, Iss. 6, 2004-01 ,pp. : 395-403

Adis International

Access to resources Recommend Favorite

Drug Persistency of Two Cholinesterase Inhibitors: Rivastigmine versus Donepezil in Elderly Patients with Alzheimer’s Disease

By Suh Dong-Churl  

Drugs & Aging, Vol. 22, Iss. 8, 2005-01 ,pp. : 695-707

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Donepezil in Patients with Alzheimer’s Disease: Results of a Global, Multinational, Clinical Experience Study

By Boada-Rovira M.  

Drugs & Aging, Vol. 21, Iss. 1, 2004-01 ,pp. : 43-53

Adis International

Access to resources Recommend Favorite